59
38
Growth Score 59 in past quarter
-7 pts
Heat Score 38 in past quarter
-13 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
624998
Virscio is a biotechnology company that develops therapeutics for central nervous system disorders such as neurodegeneration, memory
Harry H. Penner: Co - FounderPast Role: Marinus Pharmaceuticals, Co - Founder & Board of Directors- Christopher M. Stanley: Vice-President
About the Company
Virscio is a biotechnology company that develops therapeutics for central nervous system disorders such as neurodegeneration, memory loss, and obesity. The company utilizes PrimaTox, which is a predictive toxicogenomics platform that enables pharmaceutical candidate selection and pre-clinical validation. Virscio is based in Hamden, Connecticut.
